Minutes of the COMP meeting 14-15 July 2026

List of Union reference dates and frequency of submission of periodic safety update reports (PSURs)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - September 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2026, 10:00 (CEST) to 23 September 2026, 12:00 (CEST)

Human medicines European public assessment report (EPAR): mCombriax, influenza mRNA vaccine,COVID-19 mRNA vaccine, Date of authorisation: 20/04/2026, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Pegasys, peginterferon alfa-2a, Date of authorisation: 20/06/2002, Revision: 49, Status: Authorised

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Date of authorisation: 09/12/2009, Revision: 51, Status: Authorised

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Leflunomide Zentiva (previously Leflunomide Winthrop), leflunomide, Date of authorisation: 08/01/2010, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Date of authorisation: 30/09/2008, Revision: 43, Status: Authorised